Twist Bioscience (TWST) Non-Current Assets (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Non-Current Assets data on file, last reported at $352.8 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $352.8 million, up 37.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 22.12% YoY), and the FY2025 annual result was $308.9 million, up 15.45% from the prior year.
• Non-Current Assets rose to $352.8 million in Q1 2026 per TWST's latest filing, from $334.2 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $368.1 million in Q4 2022 and troughed at $257.2 million in Q1 2025.
• A 5-year average of $327.3 million and a median of $342.6 million in 2023 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets soared 415.6% in 2022, then slipped 24.26% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $368.1 million in 2022, then declined by 6.93% to $342.6 million in 2023, then decreased by 23.15% to $263.3 million in 2024, then climbed by 26.94% to $334.2 million in 2025, then climbed by 5.56% to $352.8 million in 2026.
• Business Quant data shows TWST's Non-Current Assets at $352.8 million in Q1 2026, $334.2 million in Q4 2025, and $308.9 million in Q3 2025.